January 20th, 2016

Direct-to-consumer drug ads increasingly seen as problem

AMA’s vote highlighted growing concerns among health care providers and consumers about the affordability of prescription drugs and whether marketing by drug companies artificially inflates medication costs and pressures providers to prescribe expensive medications when less costly alternatives are available.

In a statement following the vote in November, AMA’s board chair-elect, Patrice A. Harris, MD, MA, said support for “an advertising ban reflects concerns among physicians about the negative impact of commercially driven promotions and the role that marketing costs play in fueling escalating drug prices.”

Harris added that DTC “advertising also inflates demand for new and more expensive drugs, even when those drugs may not be appropriate.” “Patient inquiries obviously have to have a response, one based on clinical judgment and scientific understanding,” Manasse said. “Sometimes these ads raise an immense amount of questions, but pharmacists are conscientious about trying to educate their patients about side effects and risks and benefits.”

Read more: https://www.pharmacist.com/direct-consumer-drug-ads-increasingly-seen-problem

Comments

Add your own Comment

(optional)